| Entry |
|
|---|
| Name |
Dornase alfa (USAN/INN);
Dornase alfa (genetical recombination) (JAN);
Pulmozyme (TN) |
|---|
| Product |
|
|---|
| Formula |
C1321H1995N339O396S9
|
|---|
| Exact mass |
29231.3879
|
|---|
| Mol weight |
29249.61
|
|---|
| Remark |
| Therapeutic category: | 2290 |
|
|---|
| Efficacy |
Mucolytic |
|---|
| Disease |
|
|---|
| Comment |
Recombinant human DNase
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R05 COUGH AND COLD PREPARATIONS
R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
R05CB Mucolytics
R05CB13 Dornase alfa (desoxyribonuclease)
D03896 Dornase alfa (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Cystic Fibrosis Agents
Cystic Fibrosis Agents, Other
Dornase Alfa
D03896 Dornase alfa (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
22 Respiratory organ agents
229 Miscellaneous
2290 Miscellaneous
D03896 Dornase alfa (USAN/INN); Dornase alfa (genetical recombination) (JAN)
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D03896
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
